BRIEF-Lilly Receives Additional FDA Approval For Verzenio [Reuters]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Reuters
BRIEF-Lilly Receives Additional FDA Approval For Verzenio? | Reuters Reuters Staff 1 Min Read Feb 26 (Reuters) - Eli Lilly And Co: * LILLY RECEIVES ADDITIONAL FDA APPROVAL FOR VERZENIO (ABEMACICLIB), AS INITIAL TREATMENT FOR ADVANCED BREAST CANCER * SAYS ?NEW INDICATION BASED ON MONARCH 3 TRIAL CAN HELP MORE WOMEN LIVING WITH HR+, HER2- ADVANCED BREAST CANCER * SAYS ?RECOMMENDED DOSE OF VERZENIO IN COMBINATION WITH AI IS 150 MG ORALLY TWICE DAILY, CONTINUED UNTIL DISEASE PROGRESSION/ UNACCEPTABLE TOXICITY * SAYS ?VERZENIO IS AVAILABLE IN 4 TABLET STRENGTHS (200 MG, 150 MG, 100 MG, AND 50 MG)? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. BRIEF-Lilly Receives Additional FDA Approval For Verzenio Feb 26 (Reuters) - Eli Lilly And Co: * LILLY RECEIVES ADDITIONAL FDA APPROVAL FOR VERZENIO (ABEMACICLIB), AS INITIAL TREATMENT FOR ADVANCED BREAST C
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- IndyCar And IU Health Announce Promotions To IndyCar Medical Team [Forbes]Forbes
- Minority Health Focused Startup Mae Closes Oversubscribed Seed Funding Round to Reduce Maternal Health Disparities [Yahoo! Finance]Yahoo! Finance
- Why Eli Lilly Stock Jumped by 4% Today [Yahoo! Finance]Yahoo! Finance
- Lilly Declares Second-Quarter 2024 DividendPR Newswire
- Lilly (LLY) Reliance on International Sales: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- LLY's page on the SEC website